Clinical trial Recruiting at 1 site Interventional Ages 7 to 24

Using virtual reality to ease pain during medical procedures for young cancer patients

Official title: Impact of Virtual Reality in Hematology and Oncology for the Management of Pain During Invasive Procedures in Children, Adolescents and Young Adults, 7 to Under 25 Years in a Pilot Study

Run by Poitiers University Hospital · NCT05275881 · Data updated 2026-11-12

This study is testing if virtual reality can help young cancer patients feel less pain and anxiety during medical procedures compared to standard treatments.

More Virtual Reality trials

Quick facts

Study typeInterventional
Ages7 Years to 24 Years
SexAll
Enrollment60 (estimated)
SponsorPoitiers University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Poitiers)
StatusRecruiting
StartedOctober 13, 2022
Main results expectedNovember 13, 2026
Study endsDecember 13, 2026
Registry record updatedDecember 16, 2024
Trial IDNCT05275881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and young adults aged 7 to under 25 with hematological or oncological conditions requiring lumbar punctures or chemotherapy via implantable venous access.

Probably not a fit

Patients with cognitive impairments or contraindications to using a virtual reality headset may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to assess the feasibility of using virtual reality (VR) as a method of medical hypnosis during invasive procedures in children and young adults with cancer. Participants aged 7 to under 25 will be randomly assigned to receive either VR or standard treatment options, which include nitrous oxide and various analgesics. The study seeks to determine if VR can provide similar benefits in managing pain and anxiety as traditional methods. The research is motivated by the need for effective pain management strategies in pediatric oncology, where invasive procedures can be particularly distressing.

Why it matters

Potential benefit: If successful, this approach could significantly reduce pain and anxiety for young cancer patients undergoing invasive procedures.

How similar studies have gone: Previous studies have shown that virtual reality can effectively reduce pain and anxiety in pediatric patients, suggesting a promising avenue for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 7 to strictly under 25
* Follow-ups for hematological or oncological pathology
* With a lumbar puncture or to connection to an implantable chamber
* Patient understanding French
* Consent of parents or guardians with parental authority.
* Child informed and having given his assent

Exclusion Criteria:

* Children with cognitive impairment
* Children in absolute emergency situations
* Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the eyes, face or scalp)
* Children who have already participated in the clinical investigation
* Refusal to participate in the study
* Patients not benefiting from a social security system or not benefiting from it by the intermediary of a third person

Where it's running

  • CHU poitiers
    Poitiers, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.